Michael Ligeikis

Davol was founded in Providence, RI in 1874. Back then, the company supplied the medical community with hot water bottles and catheters. For the past 40 years, Davol has stood out as the market leader in providing solutions in soft tissue reconstruction solutions including products for hernia repair, specialized surgical procedures, fixation and biologic implants. Now a subsidiary of C.R. Bard, Inc., Davol continues to maintain its leadership position in the medical device industry with an expanded portfolio of proven, innovative solutions. These include a growing line of mesh prosthetics, biologic implants, surgical instruments and techniques for inguinal, ventral and other hernia repair procedures, plus a range of products for autotransfusion, hemostasis, laparoscopy, hysteroscopy, pulsed lavage and wound management. Researchers at Davol are constantly engaged in expanding the range of soft tissue repair, hemostasis and performance irrigation products aimed at providing exceptional reliability and value – qualities that clinicians, physicians and patients have come to depend on from Davol.